PNU-282987 Attenuates Intestinal Epithelial Barrier Dysfunction in LPS-Induced Endotoxemia

Inflammation. 2020 Apr;43(2):417-424. doi: 10.1007/s10753-019-01096-w.

Abstract

PNU-282987, the α7 acetylcholine receptor(α7nAchR) agonist, has been repeatedly reported to play a key role in anti-inflammatory action of multiple disease. However, little is known about its effect on LPS-induced intestinal epithelial barrier dysfunction. This study investigated the protective effects and mechanisms of PNU-282987 on intestinal epithelial barrier dysfunction in lipopolysaccharide(LPS)-induced endotoxemic rats. Endotoxemia models were induced by intraperitoneal injection of 10 mg/kg LPS. In the endotoxemic group, results showed increases in ileum mucosal permeability, ultrastructural damage of tight junction and redistribution of zonula occludens-1, apoptosis of intestinal epithelial cells and caspase-3 activation. These changes were significantly improved after PNU-282987 administration(P < 0.05). Pretreatment with α-bungarotoxin before PNU-282987 administration reversed the effects of PNU-282987(P < 0.05). These results indicate that PNU-282987 exerts protective effects on intestinal epithelial barrier dysfunction in LPS-induced endotoxemic rats, and its mechanism may involve the improvement of zonula occludens-1 and inhibition of enterocyte apoptosis in an α7nAchR-dependent manner.

Keywords: PNU-282987; apoptosis; intestinal permeability; tight junction; zonula occludens-1.

MeSH terms

  • Animals
  • Benzamides / pharmacology
  • Benzamides / therapeutic use*
  • Bridged Bicyclo Compounds / pharmacology
  • Bridged Bicyclo Compounds / therapeutic use*
  • Endotoxemia / chemically induced*
  • Endotoxemia / drug therapy*
  • Endotoxemia / metabolism
  • Endotoxemia / pathology
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / pathology
  • Lipopolysaccharides / toxicity*
  • Male
  • Nicotinic Agonists / pharmacology
  • Nicotinic Agonists / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Benzamides
  • Bridged Bicyclo Compounds
  • Lipopolysaccharides
  • Nicotinic Agonists
  • PNU-282987